US PATENT SUBCLASS 424 / 185.1
.~ Amino acid sequence disclosed in whole or in part; or conjugate, complex, or fusion protein or fusion polypeptide including the same

Current as of: June, 1999
Click HD for Main Headings
Click for All Classes

Internet Version by PATENTEC © 1999      Terms of Use


424 /   HD   DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS

184.1  DF  ANTIGEN, EPITOPE, OR OTHER IMMUNOSPECIFIC IMMUNOEFFECTOR (E.G., IMMUNOSPECIFIC VACCINE, IMMUNOSPECIFIC STIMULATOR OF CELL-MEDIATED IMMUNITY, IMMUNOSPECIFIC TOLEROGEN, IMMUNOSPECIFIC IMMUNOSUPPRESSOR, ETC.) {15}
185.1.~ Amino acid sequence disclosed in whole or in part; or conjugate, complex, or fusion protein or fusion polypeptide including the same {3}
186.1  DF  .~.~> Disclosed amino acid sequence derived from virus {2}
190.1  DF  .~.~> Disclosed amino acid sequence derived from bacterium (e.g., Mycoplasma, Anaplasma, etc.)
191.1  DF  .~.~> Disclosed amino acid sequence derived from parasitic organism (e.g., Dirofilaria, Eimeria, Trichinella, etc.)

DEFINITION

Classification: 424/185.1

Amino acid sequence disclosed in whole or in part; or conjugate, complex, or fusion protein or fusion polypeptide including the same:

(under subclass 184.1) Subject matter wherein an amino acid sequence specifying an antigen, an epitope, or another immunospecific immunoeffector is disclosed in whole or in

part, wherein the disclosed amino acid sequence may be part of a conjugate, a complex, or a fusion protein or fusion polypeptide.

(1) Note. A conjugate is taken to mean a coupling of one substance to another via covalent means, either directly via a covalent bond or indirectly via a chemical linking group.

(2) Note. A complex is taken to mean a coupling of one substance to another via noncovalent means (e.g., via adsorption).

(3) Note. A fusion protein or fusion polypeptide is taken to mean the expression product of a gene fusion. A gene fusion is a nucleic acid sequence that encodes the complete or partial amino acid sequences of two or more proteins or polypeptides in contiguous fashion, or in noncontiguous fashion, wherein the expressed sequence is ultimately processed to yield the desired fusion protein.